Roivant Sciences Ltd
NASDAQ:ROIV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Roivant Sciences Ltd
NASDAQ:ROIV
|
BM |
|
O
|
OSK Holdings Bhd
KLSE:OSK
|
MY |
|
Smurfit WestRock PLC
LSE:SWR
|
IE |
|
Zhengye Biotechnology Holding Ltd
NASDAQ:ZYBT
|
CN |
|
Iris Energy Ltd
NASDAQ:IREN
|
AU |
|
U
|
Ubisoft Entertainment SA
DUS:UEN
|
FR |
|
V
|
Vibhavadi Medical Center PCL
SET:VIBHA
|
TH |
|
Sensus Healthcare Inc
NASDAQ:SRTS
|
US |
|
Vera Bradley Inc
NASDAQ:VRA
|
US |
|
PTT Oil and Retail Business PCL
SET:OR
|
TH |
|
Ryanair Holdings PLC
NASDAQ:RYAAY
|
IE |
|
Finch Therapeutics Group Inc
OTC:FNCH
|
US |
|
R
|
Red Pine Exploration Inc
OTC:RDEXF
|
CA |
|
Neway CNC Equipment Suzhou Co Ltd
SSE:688697
|
CN |
|
North American Construction Group Ltd
NYSE:NOA
|
CA |
|
N
|
Nang Kuang Pharmaceutical Co Ltd
TWSE:1752
|
TW |
Wall St Price Targets
ROIV Price Targets Summary
Roivant Sciences Ltd
According to Wall Street analysts, the average 1-year price target for
ROIV is 39.36 USD with a low forecast of 31.82 USD and a high forecast of 47.25 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ROIV's stock price target?
Price Target
39.36
USD
According to Wall Street analysts, the average 1-year price target for
ROIV is 39.36 USD with a low forecast of 31.82 USD and a high forecast of 47.25 USD.
What is the Revenue forecast for Roivant Sciences Ltd?
Projected CAGR
103%
Over the last 4 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 8 years is 103%.